RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)

Condition:   Hepatocellular Carcinoma Intervention:   Drug: Radiation therapy and systemic anti-PD-1 immunotherapy for patients with advanced hepatocellular carcinoma Sponsor:   Guangxi Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials